Advanced nitric oxide generating nanomedicine for therapeutic applications
Nitric oxide (NO), a gaseous transmitter extensively present in the human body, regulates
vascular relaxation, immune response, inflammation, neurotransmission, and other crucial …
vascular relaxation, immune response, inflammation, neurotransmission, and other crucial …
Coronary In-Stent Restenosis: JACC State-of-the-Art Review
G Giustino, A Colombo, A Camaj, K Yasumura… - Journal of the American …, 2022 - jacc.org
The introduction and subsequent iterations of drug-eluting stent technologies have
substantially improved the efficacy and safety of percutaneous coronary interventions …
substantially improved the efficacy and safety of percutaneous coronary interventions …
2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on …
Writing Committee Members, JS Lawton… - Journal of the American …, 2022 - jacc.org
Aim The guideline for coronary artery revascularization replaces the 2011 coronary artery
bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines …
bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines …
Trends and outcomes of restenosis after coronary stent implantation in the United States
Background There is a paucity of data on the burden of in-stent restenosis (ISR) in the
United States as well as on its presentation and appropriate treatment strategies. Objectives …
United States as well as on its presentation and appropriate treatment strategies. Objectives …
Third universal definition of myocardial infarction
K Thygesen, JS Alpert, AS Jaffe, ML Simoons… - circulation, 2012 - Am Heart Assoc
Myocardial infarction (MI) can be recognised by clinical features, including
electrocardiographic (ECG) findings, elevated values of biochemical markers (biomarkers) …
electrocardiographic (ECG) findings, elevated values of biochemical markers (biomarkers) …
2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task …
GN Levine, ER Bates, JC Blankenship… - Journal of the American …, 2011 - jacc.org
Interventions. Copies: This document is available on the World Wide Web sites of the
American College of Cardiology (www. cardiosource. org), the American Heart Association …
American College of Cardiology (www. cardiosource. org), the American Heart Association …
[HTML][HTML] Management of in-stent restenosis
In-stent restenosis (ISR) remains the most common cause of stent failure after percutaneous
coronary intervention (PCI). Recent data suggest that ISR-PCI accounts for 5-10% of all PCI …
coronary intervention (PCI). Recent data suggest that ISR-PCI accounts for 5-10% of all PCI …
Current treatment of in-stent restenosis
Management of patients with in-stent restenosis (ISR) remains an important clinical problem.
Although drug-eluting stents (DES) have drastically reduced the incidence of ISR, treatment …
Although drug-eluting stents (DES) have drastically reduced the incidence of ISR, treatment …
Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography
Objective Systematic investigation of restenosis after percutaneous coronary intervention
(PCI) with bare metal stents (BMS) or first or second generation drug eluting stents (DES) in …
(PCI) with bare metal stents (BMS) or first or second generation drug eluting stents (DES) in …
Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting …
Y Zhu, K Liu, M Chen, Y Liu, A Gao, C Hu, H Li… - Cardiovascular …, 2021 - Springer
Abstract Background The triglyceride-glucose (TyG) index is an alternative marker of insulin
resistance (IR) and is closely associated with the prevalence and prognosis of …
resistance (IR) and is closely associated with the prevalence and prognosis of …